Clinical

This channel newsfeed includes clinical content on treating patients or the clinical implications in a variety of cardiac subspecialties and disease states. The channel includes news on cardiac surgery, interventional cardiology, heart failure, electrophysiology, hypertension, structural heart disease, use of pharmaceuticals, and COVID-19.

Texas announces childhood vaccine probe as RFK-backed group files RICO case against AAP
The Children’s Health Defense, a vaccine-skeptic lobby once chaired by HHS Secretary Robert F. Kennedy Jr., filed a complaint in federal court against the American Academy of Pediatrics, alleging it engaged in systemic corruption. The same day, Texas Attorney General Ken Paxton said his state would be investigating the financial ties between vaccine developers, insurers and pediatricians.
Medtronic’s newest all-in-one PFA catheter gains critical approval
The all-in-one mapping and single-shot PFA catheter was developed with electrophysiologist feedback in mind.
Vascular surgeon accused of double murder pleads not guilty
The 39-year-old vascular surgeon allegedly killed his ex-wife and her husband on Dec. 30. If convicted, he faces the possibility of life in prison without parole.
CVRx hopes new research will expand access to heart failure therapy
The BENEFIT-HF trial, scheduled to begin enrollment in the months ahead, could significantly increase the number of patients eligible for CVRx's Barostim therapy.
IVL competition heats up as Boston Scientific enters US market
Shockwave Medical, now a part of Johnson & Johnson MedTech, sits at the top of the IVL market, but things are starting to get more competitive. Boston Scientific gained its own IVL system when it acquired Bolt Medical in 2025.

Texas announces childhood vaccine probe as RFK-backed group files RICO case against AAP

The Children’s Health Defense, a vaccine-skeptic lobby once chaired by HHS Secretary Robert F. Kennedy Jr., filed a complaint in federal court against the American Academy of Pediatrics, alleging it engaged in systemic corruption. The same day, Texas Attorney General Ken Paxton said his state would be investigating the financial ties between vaccine developers, insurers and pediatricians.

Medtronic has secured CE mark approval for its Affera Sphere-360 catheter,

Medtronic’s newest all-in-one PFA catheter gains critical approval

The all-in-one mapping and single-shot PFA catheter was developed with electrophysiologist feedback in mind.

Vascular surgeon accused of double murder pleads not guilty

The 39-year-old vascular surgeon allegedly killed his ex-wife and her husband on Dec. 30. If convicted, he faces the possibility of life in prison without parole.

CVRx hopes new research will expand access to heart failure therapy

The BENEFIT-HF trial, scheduled to begin enrollment in the months ahead, could significantly increase the number of patients eligible for CVRx's Barostim therapy.

The Boston Scientific Seismiq intravascular lithotripsy (IVL) system entered commercial use in the U.S. in January 2026.

IVL competition heats up as Boston Scientific enters US market

Shockwave Medical, now a part of Johnson & Johnson MedTech, sits at the top of the IVL market, but things are starting to get more competitive. Boston Scientific gained its own IVL system when it acquired Bolt Medical in 2025.

Gene editing software image from Scribe Therapeutics for its STX-1150 drug to treat LDL-C.

Coming soon: First-in-human study of gene-modifying drug for hypercholesterolemia

Gene-editing drugs have shown potential to treat a wide variety of diseases, and this will be one of the first in cardiovascular medicine to begin human trials.

The DurAVR TAVR system from Anteris Technologies

Medtronic invests $90M in medtech company behind one-of-a-kind TAVR tech

Anteris Technologies is known for its biomimetic transcatheter heart valve, the DurAVR THV System. The device is the first of its kind and has gained considerable attention as the TAVR market continues to grow.

Abbott’s medtech sales climbed in Q4 thanks to strength of heart devices

Abbott pointed to double-digit growth for its Navitor TAVR valve as well as big gains for the TriClip and MitraClip devices. The company also shared positive sales figures for its EP, heart failure and rhythm management portfolios.